胎儿生长受限的高危因素及妊娠结局分析

Abstract
Figure/Table
References (16)
Related Citation (15)

Download: PDF (0 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the high-risk factors and prognosis of fetal growth restriction (FGR),so as to provide reference for prenatal consultation and treatment.Methods A total of 80 pregnant women with FGR admitted to Suzhou Hospital of Traditional Chinese Medicine Affiliated to Nanjing University of Chinese Medicine from January 1,2013 to December 31,2019 were selected as the observation group,and 80 pregnant women without FGR were selected as control group.The clinical data of the two groups were observed,and the high-risk factors and pregnancy outcomes of the two groups were analyzed..Results The maternal factors (pregnancy induced hypertension,twins,intrahepatic cholestasis of pregnancy,oligohydramnios),umbilical cord abnormality,placental abnormalities in the observation group were higher than those in the control group,the differences were statistically significant (P<0.05).The rate of neonatal asphyxia,incidence of related complications,mortality and stillbirth rate in the observation group were higher than those in the control group,the differences were statistically significant (P<0.05).Conclusion Maternal factors,placentas and umbilical cord factors are the high risk factors of fetal growth restriction.It is suggested that strict screening should be carried out in clinical antenatal examination,the propaganda and education of prenatal examination knowledge of pregnant women should be strengthened,and prenatal nutrition guidance service should be provided to promote the smooth progress of eugenics and eugenics.

Key words： Fetal growth restriction High risk factors Pregnancy outcome

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	FAN Xiao-yan
	ZHOU Yan-ping

Cite this article:

FAN Xiao-yan,ZHOU Yan-ping. Analysis of high risk factors and pregnancy outcome of fetal growth restriction[J]. 中国当代医药, 2020, 27(36): 116-118.

URL:

https://www.dangdaiyiyao.com/EN/ OR https://www.dangdaiyiyao.com/EN/Y2020/V27/I36/116

[1]	谢幸，孔北华，段涛.妇产科学[M].9版北京：人民卫生出版社，2019，135-137.
[2]	蒋晨昱，鲍晨怡，刘兴会.胎儿生长受限的诊治[J].实用妇产科杂志，2020，36（3）：170-173.
[3]	中华医学会围产医学分会胎儿医学学组，中华医学会妇产科学分会产科学组.胎儿生长受限专家共识（2019版）[J].中华围产医学杂志，2019，22（6）：361-380.
[4]	Lausman A，kingdom J，Gagnon R，et al.Intrauterine growth restiction：screening，diagnosis，and management[J].J Obstet Gynaecol Can，2013，35：741-748
[5]	American College of Obstetricians and Gynecologists′ Committee on Practice Bulletins-Obstetrics and the Society for Maternal-Fetal Medicin.ACOG Practice Bulletin No.204：Fetal Growth Restriction[J].Obstet Gynecol，2019，133（2）：e97-e109.
[6]	王影，樊阳阳，胡盈，等.妊娠期高血压疾病伴发胎儿生长受限的研究[J].中国妇幼健康研究，2020，31（1）：104-108.
[7]	王程锦.胎儿生长受限对胎儿危害的临床研究[J].国际感染病学（电子版），2020，9（1）：16.
[8]	罗晓芳，漆洪波.胎儿生长受限的胎盘因素及其临床诊治[J].中国实用妇科与产科杂志，2016，32（4）：298-302.
[9]	王卓，任秀娥，郑莉霞.彩色多普勒超声测量胎儿脐动脉、大脑中动脉和主动脉弓峡部血流参数诊断孕晚期胎儿生长受限[J].影像科学与光化学，2020，38（2）：236-241.
[10]	王琴晓，林希，焦岩，等.彩色多普勒超声综合评估在胎儿生长受限诊断中的应用价值[J].浙江医学，2020，42（10）：1014-1017，1021.
[11]	倪俊红，陈程.胎儿生长受限与小于胎龄孕妇心输出量和全身血管阻力的差异研究[J].新疆医科大学学报，2020，43（6）：745-748.
[12]	蒋晨昱，鲍晨怡，刘兴会.胎儿生长受限的诊治[J].实用妇产科杂志，2020，36（3）：170-173.
[13]	王贝，马俊莲.胎儿宫内生长受限新生儿结局及病因分析[J].浙江临床医学，2020，22（4）：543-544.
[14]	刘兆董，颜建英，郭美妹.妊娠晚期胎儿生长受限的相关影响因素及妊娠结局分析[J].中国医师杂志，2020，22（3）：361-364，368.
[15]	何敏敏，唐雅兵.妊娠10～13 周母血PAPP-A及胎盘体积对胎儿生长受限的预测价值[J].中国生育健康杂志，2019，30（6）：549-551.
[16]	文丽秀.母体凝血功能及胎儿脐血流相关参数预测特发性胎儿生长受限价值[J].中国计划生育学杂志，2019，27（9）：1183-1185.